Adhoc: Sandoz Group AG: Sandoz reports strong biosimilars growth in Q1 2026; full-year 2026 guidance confirmed

Sandoz Group AG / Key word(s): Quarter Results Sandoz reports strong biosimilars growth in Q1 2026; full-year 2026 guidance confirmed 29-Apr-2026 / 07:00 CET/CEST Release of an ad hoc announcement…

Weiterlesen auf der Quellseite

Ähnliche Beiträge